Trials / Unknown
UnknownNCT04442568
Impact of ERAS in LSG
Enhanced Recovery After Surgery Protocol in Laparoscopic Sleeve Gastrectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Umraniye Education and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Patients with BMI \>35 and chronic diseases or BMI \>40 will be scheduled to receive Laparoscopic Sleeve Gastrectomy (LSG). Two groups are planned according to receive Enhance recovery after surgery (ERAS) protocol or not. All participants will receive standard LSG. Participants of ERAS will receive anesthesia and post-surgical nutrition protocol which are determined for ERAS. All patients will be checked for status of pain with VAS score, nausea and vomiting with PONV score at postoperative 2nd hour, 12th hour. In ERAS group liquid oral intake will be started between postoperative 2nd and 4th hours. In no ERAS group liquid oral intake will be started in the morning of postoperative first day. The patients who provides discharge criterias will be discahrged. these criterias are; To provide adequate pain relief with paracetamol and nonsteroidal painkillers, No wound problem, No complications after surgery, Pulse rate \<90 beats / min, temperature ≤ 37 · 5 ° C, respiratory rate, \<20 breaths / minute, To be able to mobilize easily, To be able to drink 1 liter of water after surgery. Emergency admissions of the participants within a month after surgery will be recorded.
Conditions
- Laparoscopic Sleeve Gastrectomy
- Enhanced Recovery After Surgery
- Pain, Postoperative
- Nausea, Postoperative
- Vomiting, Postoperative
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ERAS | early mobilisation, early oral intake, early discharge |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-02-01
- Completion
- 2021-06-01
- First posted
- 2020-06-22
- Last updated
- 2020-06-29
Source: ClinicalTrials.gov record NCT04442568. Inclusion in this directory is not an endorsement.